Live from the NIH registry
Studies recruiting near Boston right now
Top 25 of 2,944 recruiting studies, sorted by proximity — each links to its official registry page
RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer
Endometrial Cancer
Phase 2
Interventional 110 participants sought
Massachusetts General Hospital Cancer Center — Boston, Massachusetts (3.0 mi)
· Sponsor: Dana-Farber Cancer Institute
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Dana-Farber Cancer Institute — Boston, Massachusetts (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis
Vascular Inflammation, ASCVD
Phase 2
Interventional 120 participants sought
Massachusetts General Hospital — Boston, Massachusetts (3.0 mi)
· Sponsor: Massachusetts General Hospital
HLA Demographics Study in Adults With Type 1 Diabetes
Diabetes Mellitus, Type I
N/A
Observational 200 participants sought
Joslin Diabetes Center — Boston, Massachusetts (3.0 mi)
· Sponsor: GentiBio, Inc
BE WELL With Migraine: Brain Education and WELLness With Migraine
Migraine
N/A
Interventional 286 participants sought
Cambridge Health Alliance - Center for Mindfulness and Compassion — Cambridge, Massachusetts (4.0 mi)
· Sponsor: Wake Forest University Health Sciences
Music Use in Parturients Admitted to Labor & Delivery
Anxiety, Pain
N/A
Interventional 106 participants sought
Tufts Medical Center — Boston, Massachusetts (3.0 mi)
· Sponsor: Tufts Medical Center
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Tufts Medical Center — Boston, Massachusetts (3.0 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Metastatic Solid Tumors
Phase 1
Interventional 600 participants sought
Massachusetts General Hospital (MG) — Boston, Massachusetts (3.0 mi)
· Sponsor: Erasca, Inc.
International Weight Control Registry
Weight Loss, Overweight
N/A
Observational 100,000 participants sought
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University — Boston, Massachusetts (3.0 mi)
· Sponsor: Tufts University
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
Graft Vs Host Disease, Acute-graft-versus-host Disease
N/A
Interventional 36 participants sought
Brigham and Women's Hospital — Boston, Massachusetts (3.0 mi)
· Sponsor: Dana-Farber Cancer Institute
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Overactive Bladder (OAB), Urinary Urgency
N/A
Interventional 596 participants sought
Curavit — Boston, Massachusetts (3.0 mi)
· Sponsor: Medstar Health Research Institute
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Local Institution - 0092 — Boston, Massachusetts (3.0 mi)
· Sponsor: Mirati Therapeutics Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Boston Veteran's Affairs Medical Center — Jamaica Plain, Massachusetts (1.9 mi)
· Sponsor: SWOG Cancer Research Network
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Diabetes Mellitus, Type 2
N/A
Interventional 119,680 participants sought
President and Fellows of Harvard College, T.H. Chan School — Boston, Massachusetts (3.0 mi)
· Sponsor: Stanford University
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Boston, Massachusetts (3.0 mi)
· Sponsor: AstraZeneca
Balloon Inflation Time for Esophageal Strictures (BITES): A Randomized Multi-Center Study
Esophageal Atresia With Tracheo-esophageal Fistula, Esophageal Atresia
N/A
Interventional 128 participants sought
Boston Children's Hospital — Boston, Massachusetts (3.0 mi)
· Sponsor: Boston Children's Hospital
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
Massachusetts General Hospital ( Site 0003) — Boston, Massachusetts (3.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation
Alzheimer Disease
N/A
Interventional 204 participants sought
677 Beacon St. Room 308 — Boston, Massachusetts (3.0 mi)
· Sponsor: Boston University Charles River Campus
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
Beth Israel Deaconess Medical Center — Boston, Massachusetts (3.0 mi)
· Sponsor: Takeda
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Newton, Massachusetts (6.5 mi)
· Sponsor: Alkermes, Inc.
Deceased Uterine Transplant in Absolute Uterine Infertility (AUIF)
Infertility of Uterine Origin
N/A
Interventional 250 participants sought
Brigham & Women's Hospital — Boston, Massachusetts (3.0 mi)
· Sponsor: Brigham and Women's Hospital
Myasthenia Gravis Foundation of America Global MG Patient Registry
Myasthaenia Gravis, Myasthenia
N/A
Observational 3,800 participants sought
Myasthenia Gravis Foundation of America — Westborough, Massachusetts (27.4 mi)
· Sponsor: Myasthenia Gravis Foundation of America
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Massachusetts — Boston, Massachusetts (3.0 mi)
· Sponsor: Jaeb Center for Health Research
CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 1, Phase 2
Interventional 12 participants sought
Massachusetts General Hospital — Boston, Massachusetts (3.0 mi)
· Sponsor: Marcela V. Maus, M.D.,Ph.D.
Prospective Screening for Breast Cancer-related Lymphedema
Lymphedema
N/A
Observational 10,000 participants sought
Massachusetts General Hospital — Boston, Massachusetts (3.0 mi)
· Sponsor: Massachusetts General Hospital